Möchten Sie immer auf dem neuesten Stand bleiben?

Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.

Beim Leserkonto Anmelden Leserkonto Erstellen

30. Januar 2026 20:50 ET | Quelle: Robbins Geller Rudman & Dowd LLP

TVTX ALERT: Investigation Launched into Travere Therapeutics, Inc., Robbins Geller Rudman & Dowd LLP Encourages Investors and Potential Witnesses to Contact Law Firm

Robbins Geller is investigating whether Travere and certain of its top executives made materially false and/or misleading statements to investors.
27. Januar 2026 07:54 ET | Quelle: Block & Leviton LLP

TVTX: Travere Therapeutics Shareholders Should Contact Block & Leviton To Potentially Recover Losses

Block & Leviton LLP is investigating Travere Therapeutics for possible securities fraud. Shareholders who lost money in TVTX should contact the firm.
13. Januar 2026 18:58 ET | Quelle: Robbins Geller Rudman & Dowd LLP

TVTX ALERT: Investigation Launched into Travere Therapeutics, Inc., RGRD Law Attorneys Encourage Investors and Potential Witnesses to Contact Law Firm

Robbins Geller is investigating whether Travere and certain of its top executives made materially false and/or misleading statements to investors.
13. Januar 2026 15:05 ET | Quelle: Block & Leviton LLP

SHAREHOLDER ALERT: Travere Therapeutics, Inc. Investigated for Securities Fraud by Block & Leviton; Investors Who Lost Money Should Contact The Firm

Block & Leviton is investigating Travere Therapeutics, Inc. (Nasdaq: TVTX) for potential securities law violations. Investors should contact the firm.